Literature DB >> 29945925

Gastrointestinal sequelae after surgery for necrotising enterocolitis: a systematic review and meta-analysis.

Eva-Maria Hau1,2, Sarah C Meyer1, Steffen Berger1, Myrofora Goutaki3,4, Marcin Kordasz1, Ulf Kessler1,5.   

Abstract

OBJECTIVES: To document what types of gastrointestinal sequelae were described after surgery for necrotising enterocolitis (NEC) and to analyse their frequency.
DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, EMBASE and the Cochrane library (CENTRAL) from 1990 to October 2016. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: We included studies, which provided original data on the occurrence of gastrointestinal sequelae in patients surviving surgery for NEC. Meta-analysis and metaregression to assess heterogeneity were performed for studies including 10 or more patients with gastrointestinal strictures, recurrence of NEC, intestinal failure (IF) and adhesion ileus.
RESULTS: Altogether 58 studies, including 4260 patients, met the inclusion criteria. Strictures were reported to occur in 24% (95% CI 17% to 31%) of surviving patients, recurrence of NEC in 8% (95% CI 3% to 15%), IF in 13% (95% CI 7% to 19%) and adhesion ileus in 6% (95% CI 4% to 9%). Strictures were more common following enterostomy (30%; 95% CI 23% to 37%) than after primary anastomosis (8%; 95% CI 0% to 23%) and occurred more often after enterostomy without bowel resection than with bowel resection. We found considerable heterogeneity in the weighted average frequency of all sequelae (I2 range: 38%-90%). Intestinal outcomes were poorly defined, there were important differences in study populations and designs, and the reported findings bear a substantial risk of bias.
CONCLUSIONS: Gastrointestinal sequelae in neonates surviving surgery for NEC are frequent. Long-term follow-up assessing defined gastrointestinal outcomes is warranted. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  NEC; necrotising enterocolitis; outcome; sequelae

Mesh:

Year:  2018        PMID: 29945925     DOI: 10.1136/archdischild-2017-314435

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  6 in total

1.  Effects of Taro (Colocasia esculenta) Water-Soluble Non-Starch Polysaccharide, Lactobacillus acidophilus, Bifidobacterium breve, Bifidobacterium infantis, and Their Synbiotic Mixtures on Pro-Inflammatory Cytokine Interleukin-8 Production.

Authors:  Mylene Anwar; Sonya Mros; Michelle McConnell; Alaa El-Din A Bekhit
Journal:  Nutrients       Date:  2022-05-19       Impact factor: 6.706

2.  The Mean Platelet Volume Combined with Procalcitonin as an Early Accessible Marker Helps to Predict the Severity of Necrotizing Enterocolitis in Preterm Infants.

Authors:  Na Cai; Wei Liao; Zhiqiang Chen; Min Tao; Sheng Chen
Journal:  Int J Gen Med       Date:  2022-04-08

3.  FEEding DURing red cell transfusion (FEEDUR RCT): a multi-arm randomised controlled trial.

Authors:  Tim Schindler; Kee Thai Yeo; Srinivas Bolisetty; Joanna Michalowski; Alvin Hock Kuan Tan; Kei Lui
Journal:  BMC Pediatr       Date:  2020-07-14       Impact factor: 2.125

4.  Congenital Heart Disease Increases Mortality in Neonates With Necrotizing Enterocolitis.

Authors:  Ulf Kessler; Eva-Maria Hau; Marcin Kordasz; Stephanie Haefeli; Catherine Tsai; Peter Klimek; Dietmar Cholewa; Mathias Nelle; Mladen Pavlovic; Steffen Berger
Journal:  Front Pediatr       Date:  2018-10-23       Impact factor: 3.418

Review 5.  Necrotizing enterocolitis and congenital heart disease.

Authors:  Hadi Kashif; Eyad Abuelgasim; Nafisa Hussain; Jessica Luyt; Amer Harky
Journal:  Ann Pediatr Cardiol       Date:  2022-03-25

6.  Association of gastric residual volumes with necrotising enterocolitis in extremely preterm infants-a case-control study.

Authors:  Gajanan Purohit; Puja Mehkarkar; Gayatri Athalye-Jape; Elizabeth Nathan; Sanjay Patole
Journal:  Eur J Pediatr       Date:  2021-07-17       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.